Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. [electronic resource]
Producer: 20080314Description: 351-5 p. digitalISSN:- 1468-2079
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Drug Administration Schedule
- Female
- Fovea Centralis -- pathology
- Humans
- Injections
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Retinal Vein Occlusion -- complications
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- drug effects
- Vitreous Body
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.